| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Simon Mark | Director | C/O CABALETTA BIO, INC., 2929 ARCH STREET, SUITE 600, PHILADELPHIA | /s/ Michael Gerard, Attorney-in-Fact | 09 Jun 2025 | 0001400717 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CABA | Stock Option (Right to Buy) | Award | $0 | +22,000 | $0.000000 | 22,000 | 09 Jun 2025 | Common Stock | 22,000 | $2.37 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | This option shall vest in full upon the earlier of (i) June 9, 2026 or (ii) the date of the next annual meeting of the Corporation's stockholders. |